These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 23787233)

  • 1. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion.
    Plicht B; Konorza TF; Kahlert P; Al-Rashid F; Kaelsch H; Jánosi RA; Buck T; Bachmann HS; Siffert W; Heusch G; Erbel R
    JACC Cardiovasc Interv; 2013 Jun; 6(6):606-13. PubMed ID: 23787233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device.
    Cruz-Gonzalez I; Martín Moreiras J; García E
    Catheter Cardiovasc Interv; 2011 Nov; 78(6):970-3. PubMed ID: 21523900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device.
    Sedaghat A; Schrickel JW; Andrié R; Schueler R; Nickenig G; Hammerstingl C
    JACC Clin Electrophysiol; 2017 Jan; 3(1):71-75. PubMed ID: 29759698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.
    Saw J; Tzikas A; Shakir S; Gafoor S; Omran H; Nielsen-Kudsk JE; Kefer J; Aminian A; Berti S; Santoro G; Nietlispach F; Moschovitis A; Cruz-Gonzalez I; Stammen F; Tichelbäcker T; Freixa X; Ibrahim R; Schillinger W; Meier B; Sievert H; Gloekler S
    JACC Cardiovasc Interv; 2017 Feb; 10(4):391-399. PubMed ID: 28231907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
    Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device).
    Lam SC; Bertog S; Sievert H
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):321-7. PubMed ID: 24550125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double device left atrial appendage closure.
    Guérios ÊE; Gloekler S; Schmid M; Khattab A; Nietlispach F; Meier B
    EuroIntervention; 2015 Aug; 11(4):470-6. PubMed ID: 25007782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.
    Jalal Z; Iriart X; Dinet ML; Selly JB; Tafer N; Renou P; Sibon I; Thambo JB
    Arch Cardiovasc Dis; 2016 Dec; 109(12):659-666. PubMed ID: 27402154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Left Atrial Appendage Ejection Velocities with the CHADS2 and CHA2DS2-VASc Scores.
    Clark CB; Telles Garcia NA; Hackett Renner C; Ryan SM
    Echocardiography; 2016 Aug; 33(8):1195-201. PubMed ID: 27060690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.